DK1546185T3 - Fremgangsmåde til fremstilling af væksthormon og antagonist deraf med lavere niveauer af isoform-urenheder deraf - Google Patents

Fremgangsmåde til fremstilling af væksthormon og antagonist deraf med lavere niveauer af isoform-urenheder deraf

Info

Publication number
DK1546185T3
DK1546185T3 DK03799266T DK03799266T DK1546185T3 DK 1546185 T3 DK1546185 T3 DK 1546185T3 DK 03799266 T DK03799266 T DK 03799266T DK 03799266 T DK03799266 T DK 03799266T DK 1546185 T3 DK1546185 T3 DK 1546185T3
Authority
DK
Denmark
Prior art keywords
growth hormone
isoform impurities
antagonist
impurities
production
Prior art date
Application number
DK03799266T
Other languages
English (en)
Inventor
Anurag S Rathore
Stephen B Lyle
David E Steinmeyer
Scott I Allen
John Meyer
Denis M Boyle
John J Buckley
Gary V Johnson
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Application granted granted Critical
Publication of DK1546185T3 publication Critical patent/DK1546185T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK03799266T 2002-08-28 2003-08-26 Fremgangsmåde til fremstilling af væksthormon og antagonist deraf med lavere niveauer af isoform-urenheder deraf DK1546185T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40655302P 2002-08-28 2002-08-28
US10/646,798 US20040048315A1 (en) 2002-08-28 2003-08-25 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
PCT/US2003/026498 WO2004031213A1 (en) 2002-08-28 2003-08-26 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof

Publications (1)

Publication Number Publication Date
DK1546185T3 true DK1546185T3 (da) 2009-06-22

Family

ID=31997673

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03799266T DK1546185T3 (da) 2002-08-28 2003-08-26 Fremgangsmåde til fremstilling af væksthormon og antagonist deraf med lavere niveauer af isoform-urenheder deraf

Country Status (21)

Country Link
US (2) US20040048315A1 (da)
EP (1) EP1546185B1 (da)
JP (1) JP4312154B2 (da)
KR (1) KR101176588B1 (da)
AT (1) ATE428721T1 (da)
AU (1) AU2003260045B2 (da)
BR (1) BRPI0313829B1 (da)
CA (1) CA2497146C (da)
CY (1) CY1109167T1 (da)
DE (1) DE60327228D1 (da)
DK (1) DK1546185T3 (da)
ES (1) ES2323586T3 (da)
HK (1) HK1077074A1 (da)
IL (1) IL167121A (da)
MX (1) MXPA05002359A (da)
PL (1) PL211502B1 (da)
PT (1) PT1546185E (da)
RU (1) RU2337920C2 (da)
SI (1) SI1546185T1 (da)
TW (2) TWI289603B (da)
WO (1) WO2004031213A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048315A1 (en) 2002-08-28 2004-03-11 Pharmacia Corporation Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
ES2344120T3 (es) * 2004-12-29 2010-08-18 Novo Nordisk Health Care Ag Metodo para prevenir la formacion de derivados de trisulfuro de polipeptidos.
US9005926B2 (en) 2009-10-02 2015-04-14 Biogen Idec Ma Inc. Methods of preventing and removing trisulfide bonds
WO2011073235A1 (en) * 2009-12-18 2011-06-23 Csl Ltd. Method of purifying polypeptides
EP3388443A1 (en) 2011-05-13 2018-10-17 Biogen MA Inc. Methods of preventing and removing trisulfide bonds
EP2748178B1 (en) 2011-08-25 2018-10-31 F. Hoffmann-La Roche AG Cation and anion exchange chromatography method
MY198629A (en) 2014-07-24 2023-09-11 Genentech Inc Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond
SG11201809959PA (en) * 2016-05-10 2018-12-28 Genentech Inc Methods of decreasing trisulfide bonds during recombinant production of polypeptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153265A (en) 1988-01-20 1992-10-06 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5969109A (en) 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
DK44593D0 (da) * 1993-04-20 1993-04-20 Novo Nordisk As Fremgangsmaade til fremstilling af et polypeptid
ZA955789B (en) * 1994-07-15 1996-03-11 Novo Nordisk As A method of converting a hydrophobic derivative of a polypeptide into the native form
AU718439B2 (en) * 1995-09-21 2000-04-13 Genentech Inc. Human growth hormone variants
SE9802454D0 (sv) * 1998-07-08 1998-07-08 Pharmacia & Upjohn Ab Production of peptides
AR026743A1 (es) * 1999-12-09 2003-02-26 Pharmacia Ab Produccion de peptidos
US7229789B1 (en) 2001-01-19 2007-06-12 N.V. Organon Methods and compositions for extracting proteins from cells
US20040048315A1 (en) 2002-08-28 2004-03-11 Pharmacia Corporation Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
ZA200502320B (en) * 2002-09-20 2006-10-25 Pharmacia Corp Process for decreasing aggregate levels of pegylated protein

Also Published As

Publication number Publication date
MXPA05002359A (es) 2005-07-15
KR20050059163A (ko) 2005-06-17
PL211502B1 (pl) 2012-05-31
BRPI0313829B1 (pt) 2021-10-26
SI1546185T1 (sl) 2009-08-31
TWI289603B (en) 2007-11-11
US8148331B2 (en) 2012-04-03
HK1077074A1 (en) 2006-02-03
DE60327228D1 (de) 2009-05-28
AU2003260045B2 (en) 2010-01-07
RU2337920C2 (ru) 2008-11-10
IL167121A (en) 2010-11-30
US20100021966A1 (en) 2010-01-28
EP1546185B1 (en) 2009-04-15
JP2006517091A (ja) 2006-07-20
EP1546185A4 (en) 2006-09-06
EP1546185A1 (en) 2005-06-29
ATE428721T1 (de) 2009-05-15
CY1109167T1 (el) 2014-07-02
AU2003260045A1 (en) 2004-04-23
CA2497146A1 (en) 2004-04-15
TW200407428A (en) 2004-05-16
ES2323586T3 (es) 2009-07-21
WO2004031213A1 (en) 2004-04-15
RU2005109388A (ru) 2005-10-27
PT1546185E (pt) 2009-07-14
PL374917A1 (en) 2005-11-14
US20040048315A1 (en) 2004-03-11
CA2497146C (en) 2012-05-22
BR0313829A (pt) 2005-07-26
KR101176588B1 (ko) 2012-08-23
TW200700553A (en) 2007-01-01
JP4312154B2 (ja) 2009-08-12

Similar Documents

Publication Publication Date Title
HK1077074A1 (en) Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
DK0763128T3 (da) Fremgangsmåde til fremstilling af heterologe bispecifikke antistoffer
ATE466030T1 (de) Neues screening-verfahren
DK1015575T3 (da) Shuffling af heterologe DNA-sekvenser
TW200505939A (en) Process for production of cyclic peptides
DK1819816T3 (da) Fremgangsmåder til fremstilling og udskillelse af modificerede peptider
WO2003064619A3 (en) Long-acting hormone and growth factor compositions and uses thereof
ATE300052T1 (de) Verwendung von radioliganden zum screening von inhibitoren der herstellung von beta-amyloid peptiden
HK1079798A1 (en) Process for decreasing aggregate levels of pegylated protein
NO930428L (no) Proteinstrukturen til plantetoksingelonin
DE60314132D1 (de) Methode zur produktion monoklonaler antikörper
EA199700310A1 (ru) Биологический способ получения соединений дипептидной природы
ATE511644T1 (de) Neues screening-verfahren
AR041070A1 (es) Metodo para la preparacion de hormona de crecimiento y de un antagonista de la misma que contiene niveles reducidos de sus isoformas como impurezas
WO2003057842A3 (en) Aggrecanase molecules